Irvine and Pasadena, CA – Sept. 28, 2020 – Early results of an experimental vaping study have shown significant lung injury from E-cigarette (eC) devices with nickel-chromium alloy heating elements. The findings were consistent, with or without the use of nicotine, vitamin E oil or tetrahydrocannabinol (THC), which have previously been thought to contribute to…
Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children’s Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) for use in the treatment of patients with hypereosinophilic syndrome. Hypereosinophilic syndrome, also known as HES, is a life-threatening group of blood disorders…
LOS ANGELES — UCLA researchers have received a $13 million grant from the National Institutes of Health to find new ways to overcome melanoma resistance to some of the most promising targeted therapies and immunotherapies. There have been significant advancements in the past decade using targeted therapies and immunotherapies for treating people with advanced forms…
DES PLAINES, IL — Antacid monotherapy is more effective in relieving epigastric pain than in combination with lidocaine. That is the conclusion of a study to be published in the September 2020 issue of Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM). The lead author of the single-center study…
The era of the television brought with it the TV dinner — a fast, convenient meal that, while nutritionally questionable, meant the whole family could gather together on the sofa to enjoy “The Ed Sullivan Show” and eat their Swanson Salisbury steak, too. Over the next several decades, advancements in technology and the ubiquity of…